Apomorphine infusion for improving sleep in Parkinson's disease

Lancet Neurol. 2022 May;21(5):395-398. doi: 10.1016/S1474-4422(22)00128-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Apomorphine* / pharmacology
  • Apomorphine* / therapeutic use
  • Humans
  • Infusions, Subcutaneous
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Sleep

Substances

  • Antiparkinson Agents
  • Apomorphine